China Bariatric Surgery Devices Market Analysis

China Bariatric Surgery Devices Market Executive Summary

The China Bariatric Surgery Devices Market is at around $213.8 Mn in 2023 and is projected to reach $336.7 Mn in 2030, exhibiting a CAGR of 6.7% during the forecast period 2023-2030.

The purpose of gastric bypass and other weight-loss surgeries, often known as bariatric or metabolic surgery, is to alter your digestive system in order to help you lose weight. Bariatric surgery is done if diet and exercise haven't improved your weight-related health problems. The amount of food you can eat is limited by some diet plans. Some work by reducing the body's ability to absorb fat and calories. Certain methods serve both purposes. While there are numerous advantages to bariatric surgery, there are risks and adverse effects associated with any large weight-loss procedure. For bariatric surgery to be successful in the long run, you must also engage in regular exercise and make long-term, healthy dietary modifications. Bariatric surgery poses potential health risks, both in the short term and the long term. Bariatric surgery risks can include excessive bleeding, infection, reactions to anaesthesia, blood clots, lung or breathing problems etc. Longer-term risks and complications of weight-loss surgery vary depending on the type of surgery. they can include bowel obstruction, dumping syndrome, a condition that leads to diarrhoea, flushing, light-headedness, nausea or vomiting, gallstones, hernias, hypoglycaemia, malnutrition, ulcers etc.

Obesity is a growing concern in China, according to Global Obesity Observatory, the prevalence of obesity and overweight is more common in men than female, the prevalence in males is 36.4% and females is 28.9%. Therefore, the market is driven by various factors such as increasing demand for minimally invasive surgeries, rising incidence of obesity, technological advancements, rising awareness about bariatric surgery.

The prominent players in the market are MicroTech Medical, Zhejiang Xlzt Med Co, Beijing Rixin Technology Co, Medtronic, B. Braun among others.

Market Dynamics

Market Drivers

Rising obesity rates in China: China has been experiencing a steady increase in obesity rates over the past few decades. Obesity is a growing concern in China, according to Global Obesity Observatory, the prevalence of obesity and overweight is more common in men than female, the prevalence in males is 36.4% and females is 28.9%. This trend is likely to continue, creating a larger potential patient pool for bariatric surgeries and driving demand for related devices.

Increasing public knowledge of obesity: Awareness of the significant health risks linked to obesity, such as type 2 diabetes, cardiovascular disease, and certain cancers, is on the rise. This growing understanding is driving more people to seek effective, long-term weight loss solutions like bariatric surgery, contributing to the market's expansion.

Increasing cases of associated comorbidities: Hypertension, Diabetics and other life style disorders are about twice as prevalent in men and women with obesity as in those with a normal weight. Thus, the increasing rate comorbidities associated to obesity is driving the market of bariatric surgery devices market.

Market Restraints

Postoperative Complications and Challenges: Bariatric surgeries can be associated with various postoperative complications, such as leaks, bleeding, infections, nutritional deficiencies, and other issues. These challenges deter patients from undergoing the procedures, restraining the growth of the devices market.

Limited of surgeons: There's a shortage of surgeons specially trained in bariatric procedures in China, leading to long wait times in some regions. This shortage limits market growth and patient access to these treatments.

Poor Healthcare Infrastructure and Lack of Reimbursement: Inadequate healthcare infrastructure in certain regions can limit the availability and quality of bariatric surgery services. The lack of reimbursement policies for these procedures also makes them unaffordable for many patients, restraining market growth.

Regulatory Landscape and Reimbursement Scenario

The National Medical Products Administration (NMPA), formerly known as the China Food and Drug Administration (CFDA), is the primary regulatory authority overseeing the approval and safety of medical devices, including those used in bariatric surgery. The National Health Commission (NHC) formulates health policies and standards at the national level.

For reimbursement, the National Healthcare Security Administration (NHSA) plays a crucial role in determining coverage and pricing for medical treatments and devices under the national insurance schemes. The Chinese Society for Metabolic and Bariatric Surgery (CSMBS) provides clinical guidelines and professional standards for bariatric procedures. The Center for Medical Device Evaluation (CMDE), operating under the NMPA, conducts technical reviews of medical devices.

Competitive Landscape

Key Players

Here are some of the major key players in the China Bariatric Surgery Devices Market:

• MicroTech Medical
• Beijing Rixin Technology Co
• Changzhou Tongchuang Medical Products Co
• Suzhou Tiansong Medical Instrument Co
• Medtronic plc.
• Ethicon, Inc. (Johnson & Johnson)
• B Braun
• Cousin Surgery
• Olympus Corporation
• SPATZ FIGA, Inc.
• Teleflex Incorporated